{"artifact":{"id":"experiment-exp-ecdfc305-fcd8-4767-b8cd-a70c9cfa9834","artifact_type":"experiment","entity_ids":"[\"NAMPT\"]","title":"FK866 treatment in DSS-induced colitis mouse model","quality_score":0.9,"created_by":"experiment_extractor","provenance_chain":"[]","content_hash":"9630e364226068a82465b4aac15ea8efc2614e21d1361791407d42a5f5b7ede2","metadata":{"_origin":{"url":null,"type":"internal","tracked_at":"2026-04-10T14:44:04.648064"},"p_value":null,"protocol":"DSS administration to induce colitis followed by FK866 treatment with assessment of mucosal NAD levels, enzyme activities, inflammatory cell infiltration, and cytokine production","effect_size":null,"sample_size":null,"source_pmid":"28877980","extracted_at":"2026-04-10T07:44:04.645402","_schema_version":1,"experiment_type":"animal_model","success_criteria":"Reduced colitis severity, decreased inflammatory markers, and altered immune cell populations","expected_outcomes":"FK866 would reduce inflammation by depleting NAD and inhibiting inflammatory pathways","statistical_methods":null},"created_at":"2026-04-10T14:44:04-07:00","updated_at":"2026-04-10T14:44:04-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-10T14:44:04-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":"ok","contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"bc5013ac-a662-479a-9f58-cbeb9564a120","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"experiment_extractor"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"paper-28877980","link_type":"derives_from","strength":1.0,"evidence":"Extracted from paper abstract/full text"},{"target_artifact_id":"experiment-exp-7083c4d7-bc53-40b1-9d97-6340b092c977","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"target_artifact_id":"experiment-exp-668ff0ed-593d-4597-a9d6-fbd6212e8247","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"target_artifact_id":"experiment-exp-383c7be4-05e7-4bfc-90d8-fb74be80ae90","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"target_artifact_id":"experiment-exp-1b9080ed-15f9-487f-88f5-94550da6ce15","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"target_artifact_id":"notebook-5fe67c33ef68","link_type":"related","strength":0.125,"evidence":"Shared entity overlap (Jaccard=0.12)"},{"target_artifact_id":"wiki-proteins-parp1-protein","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: PARP1"},{"target_artifact_id":"wiki-genes-nampt","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: NAMPT"},{"target_artifact_id":"wiki-proteins-nadk-protein","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: NAD"},{"target_artifact_id":"wiki-proteins-parp1","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: PARP1"},{"target_artifact_id":"wiki-genes-parp1","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: PARP1"},{"target_artifact_id":"wiki-therapeutics-nmn-nad-precursor-parkinsons","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: NAD"},{"target_artifact_id":"wiki-mechanisms-nad-metabolism-pathway-neurodegeneration","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: NAD"},{"target_artifact_id":"wiki-genes-cd38","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: CD38"},{"target_artifact_id":"wiki-ideas-cd38-inhibition-nad-synergy","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: CD38"},{"target_artifact_id":"wiki-therapeutics-nad-precursors-neurodegeneration","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: NAD"},{"target_artifact_id":"wiki-therapeutics-cd38-inhibitor-therapy-neurodegeneration","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: CD38"},{"target_artifact_id":"wiki-therapeutics-nad-precursor-therapy","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: NAD"},{"target_artifact_id":"wiki-mechanisms-nad-bioenergetics-investment-synthesis","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: NAD"},{"target_artifact_id":"wiki-proteins-nampt-protein","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: NAMPT"},{"target_artifact_id":"wiki-ideas-parp1-inhibition-parthanatos-prevention","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: PARP1"},{"target_artifact_id":"wiki-therapeutics-nad-boosters","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: NAD"},{"target_artifact_id":"wiki-mechanisms-nad-signaling-neurodegeneration","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: NAD"},{"target_artifact_id":"wiki-therapeutics-nad-boosters-neurodegeneration","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: NAD"},{"target_artifact_id":"wiki-experiments-nad-augmentation-therapy-early-ad","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: NAD"},{"target_artifact_id":"wiki-mechanisms-nad-metabolism-neurodegeneration","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: NAD"},{"target_artifact_id":"wiki-genes-nampt","link_type":"mentions","strength":0.9,"evidence":"target_gene: NAMPT"},{"target_artifact_id":"wiki-genes-parp1","link_type":"mentions","strength":0.5,"evidence":"Entity PARP1 in experiment"},{"target_artifact_id":"wiki-genes-cd38","link_type":"mentions","strength":0.5,"evidence":"Entity CD38 in experiment"}],"incoming_links":[{"source_artifact_id":"wiki-proteins-parp1-protein","link_type":"mentions","strength":0.7,"evidence":"Gene mention: PARP1"},{"source_artifact_id":"wiki-genes-nampt","link_type":"mentions","strength":0.8,"evidence":"Gene target: NAMPT"},{"source_artifact_id":"wiki-proteins-nadk-protein","link_type":"mentions","strength":0.7,"evidence":"Gene mention: NAD"},{"source_artifact_id":"wiki-proteins-parp1","link_type":"mentions","strength":0.7,"evidence":"Gene mention: PARP1"},{"source_artifact_id":"wiki-genes-parp1","link_type":"mentions","strength":0.7,"evidence":"Gene mention: PARP1"},{"source_artifact_id":"wiki-therapeutics-nmn-nad-precursor-parkinsons","link_type":"mentions","strength":0.7,"evidence":"Gene mention: NAD"},{"source_artifact_id":"wiki-mechanisms-nad-metabolism-pathway-neurodegeneration","link_type":"mentions","strength":0.7,"evidence":"Gene mention: NAD"},{"source_artifact_id":"wiki-genes-cd38","link_type":"mentions","strength":0.7,"evidence":"Gene mention: CD38"},{"source_artifact_id":"wiki-ideas-cd38-inhibition-nad-synergy","link_type":"mentions","strength":0.7,"evidence":"Gene mention: CD38"},{"source_artifact_id":"wiki-therapeutics-nad-precursors-neurodegeneration","link_type":"mentions","strength":0.7,"evidence":"Gene mention: NAD"},{"source_artifact_id":"wiki-therapeutics-cd38-inhibitor-therapy-neurodegeneration","link_type":"mentions","strength":0.7,"evidence":"Gene mention: CD38"},{"source_artifact_id":"wiki-therapeutics-nad-precursor-therapy","link_type":"mentions","strength":0.7,"evidence":"Gene mention: NAD"},{"source_artifact_id":"wiki-mechanisms-nad-bioenergetics-investment-synthesis","link_type":"mentions","strength":0.7,"evidence":"Gene mention: NAD"},{"source_artifact_id":"wiki-proteins-nampt-protein","link_type":"mentions","strength":0.8,"evidence":"Gene target: NAMPT"},{"source_artifact_id":"wiki-ideas-parp1-inhibition-parthanatos-prevention","link_type":"mentions","strength":0.7,"evidence":"Gene mention: PARP1"},{"source_artifact_id":"wiki-therapeutics-nad-boosters","link_type":"mentions","strength":0.7,"evidence":"Gene mention: NAD"},{"source_artifact_id":"wiki-mechanisms-nad-signaling-neurodegeneration","link_type":"mentions","strength":0.7,"evidence":"Gene mention: NAD"},{"source_artifact_id":"wiki-therapeutics-nad-boosters-neurodegeneration","link_type":"mentions","strength":0.7,"evidence":"Gene mention: NAD"},{"source_artifact_id":"wiki-experiments-nad-augmentation-therapy-early-ad","link_type":"mentions","strength":0.7,"evidence":"Gene mention: NAD"},{"source_artifact_id":"wiki-mechanisms-nad-metabolism-neurodegeneration","link_type":"mentions","strength":0.7,"evidence":"Gene mention: NAD"},{"source_artifact_id":"experiment-exp-668ff0ed-593d-4597-a9d6-fbd6212e8247","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"source_artifact_id":"experiment-exp-7083c4d7-bc53-40b1-9d97-6340b092c977","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"source_artifact_id":"experiment-exp-383c7be4-05e7-4bfc-90d8-fb74be80ae90","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"source_artifact_id":"experiment-exp-1b9080ed-15f9-487f-88f5-94550da6ce15","link_type":"related","strength":1.0,"evidence":"Shared entity overlap (Jaccard=1.00)"},{"source_artifact_id":"notebook-5fe67c33ef68","link_type":"related","strength":0.6,"evidence":"Both artifacts share KG entity: 'nampt'"},{"source_artifact_id":"wiki-therapeutics-sirtuin-modulators-parkinsons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: NAMPT mentioned 2x in wiki/therapeutics-sirtuin-modulators-parkinsons"},{"source_artifact_id":"wiki-therapeutics-nicotinamide-riboside","link_type":"mentions","strength":0.5,"evidence":"Content: NAMPT mentioned 4x in wiki/therapeutics-nicotinamide-riboside"},{"source_artifact_id":"wiki-therapeutics-section-103-sirtuin-nad-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: NAMPT mentioned 3x in wiki/therapeutics-section-103-sirtuin-nad-cbs-psp"},{"source_artifact_id":"wiki-hypotheses-sirtuin-pathway-dysfunction-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: NAMPT mentioned 8x in wiki/hypotheses-sirtuin-pathway-dysfunction-parkinsons"},{"source_artifact_id":"wiki-cell-types-ventral-tegmental-area-expanded","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: NAMPT mentioned 2x in wiki/cell-types-ventral-tegmental-area-expanded"},{"source_artifact_id":"wiki-cell-types-ventral-tegmental-area","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: NAMPT mentioned 2x in wiki/cell-types-ventral-tegmental-area"},{"source_artifact_id":"wiki-mechanisms-wallerian-degeneration","link_type":"mentions","strength":0.5,"evidence":"Content: NAMPT mentioned 3x in wiki/mechanisms-wallerian-degeneration"},{"source_artifact_id":"wiki-mechanisms-circadian-disruption-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: NAMPT mentioned 3x in wiki/mechanisms-circadian-disruption-parkinsons"},{"source_artifact_id":"wiki-brain-regions-ventral-tegmental-area","link_type":"mentions","strength":0.5,"evidence":"Content: NAMPT mentioned 3x in wiki/brain-regions-ventral-tegmental-area"}],"current_artifact_id":"experiment-exp-ecdfc305-fcd8-4767-b8cd-a70c9cfa9834","is_canonical":true,"supersede_chain":["experiment-exp-ecdfc305-fcd8-4767-b8cd-a70c9cfa9834"]}